Cargando…
Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
Mycobacterium abscessus is a rapid-growing, multidrug-resistant, non-tuberculous mycobacterial species responsible for a variety of human infections, such as cutaneous and pulmonary infections. M. abscessus infections are very difficult to eradicate due to the natural and acquired multidrug resistan...
Autores principales: | Kim, Tae Ho, Hanh, Bui Thi Bich, Kim, Guehye, Lee, Da-Gyum, Park, June-Woo, Lee, So Eui, Kim, Jae-Sung, Kim, Byoung Soo, Ryoo, Sungweon, Jo, Eun-Kyeong, Jang, Jichan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943738/ https://www.ncbi.nlm.nih.gov/pubmed/31835481 http://dx.doi.org/10.3390/molecules24244511 |
Ejemplares similares
-
Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Pathogen Box screening for hit identification against Mycobacterium abscessus
por: Jeong, Jinsun, et al.
Publicado: (2018) -
10-DEBC Hydrochloride as a Promising New Agent against Infection of Mycobacterium abscessus
por: Lee, Da-Gyum, et al.
Publicado: (2022) -
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)